Skip to main content
Clinical Trials/NCT04118257
NCT04118257
Completed
Not Applicable

Effects of Short-term Sugary Beverage Consumption on Type-2 Diabetes and Cardiovascular Disease Risk Factors: A Randomized Controlled Trial

Kansas State University1 site in 1 country37 target enrollmentFebruary 10, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Metabolic Syndrome
Sponsor
Kansas State University
Enrollment
37
Locations
1
Primary Endpoint
Change in glucose iAUC
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Our goal is to determine how the addition of sugar-sweetened beverages to the diet affects glucose control, cardiovascular disease risk factors, and pulmonary function in healthy, young adults.

Detailed Description

In a 3-arm randomized controlled trial, 36 participants consumed one of three beverages for three weeks: water (W), caffeine-free soda (S), or 100% fruit juice (FJ). Participants consumed two servings/day (\~710mL) of their randomized beverage for three weeks, along with their habitual diets. At baseline and following the 3-week intervention, participants completed glucose control, cardiovascular disease risk factor, and pulmonary function assessments.

Registry
clinicaltrials.gov
Start Date
February 10, 2017
End Date
November 14, 2018
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sara K Rosenkranz

Principal Investigator

Kansas State University

Eligibility Criteria

Inclusion Criteria

  • Free from diagnosis of diabetes and pulmonary illness
  • Have no intake of glucose or lipid lowering medication.

Exclusion Criteria

  • Currently pregnant
  • Have bronchitis
  • Have more than 2 risk factors for cardiovascular disease, as defined by the American College of Sports Medicine (ACSM).

Outcomes

Primary Outcomes

Change in glucose iAUC

Time Frame: Week 0 and Week 3

Glucose obtained from blood sample in a fasted state and in response to a meal

Secondary Outcomes

  • Change in plasma lipids(Week 0 and Week 3)
  • Change in blood pressure(Week 0 and Week 3)
  • Change in serum fructosamine(Week 0 and Week 3)
  • Change in insulin iAUC(Week 0 and Week 3)
  • Change in homeostatic model assessment for insulin resistance(Week 0 and Week 3)
  • Change in BMI(Week 0 and Week 3)
  • Change in pulmonary function(Week 0 and Week 3)

Study Sites (1)

Loading locations...

Similar Trials